Our finding indicates the feasibility of employing TSH targeting TSHR via CAR‐T cells for treating advanced thyroid cancer, presenting a new therapeutic strategy for DTC patients facing recurrence, metastasis, and radioactive iodine therapy resistance. The gene discussed is TSHR; the disease is thyroid cancer.